Publications (171) JUAN JOSÉ PICAZO DE LA GARZA publications

2019

  1. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study

    Vaccine, Vol. 37, Núm. 16, pp. 2200-2207

2018

  1. Effects of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants aged 0 to 90 days in Madrid, Spain

    Journal of the Pediatric Infectious Diseases Society

2017

  1. Characterization and circulation of seasonal influenza viruses in Madrid, 2010-2016

    Journal of Medical Virology, Vol. 89, Núm. 10, pp. 1726-1733

  2. Consenso sobre la vacunación anti-neumocócica en el adulto por riesgo de edad y patología de base. Actualización 2017

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 2, pp. 142-168

  3. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing enterobacteriaceae

    Journal of Medical Microbiology, Vol. 66, Núm. 2, pp. 169-174

  4. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015

    PLoS ONE, Vol. 12, Núm. 2

  5. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children

    Vaccine, Vol. 35, Núm. 35, pp. 4646-4651

  6. In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 2, pp. 191-196

  7. Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2016

  1. Compendio de microbiología lit. ed.

    Elsevier

  2. Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses

    Journal of Medical Microbiology, Vol. 65, Núm. 6, pp. 456-461

2015

  1. Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 10, pp. 5959-5966

  2. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates

    Microbial Drug Resistance

  3. Could ceftaroline be an alternative therapy for linezolid resistant staphylococcus epidermidis infections in intensive care medicine?

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 4, pp. 214-216

  4. El desarrollo de nuevas vacunas

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 8, pp. 557-568

  5. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains

    International Journal of Antimicrobial Agents

  6. Update in infectious diseases 2015

    Revista Espanola de Quimioterapia, Vol. 28, pp. 1-4

2014

  1. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: High percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 460-464

  2. Osteomielitis esternal y mediastinitis por fusobacterium necrophorum

    Revista Espanola de Quimioterapia

  3. Recomendaciones de vacunación frente a neumococo en enfermos renales en España

    Nefrologia, Vol. 34, Núm. 5, pp. 545-551